Geron (GERN) Inventory Average (2024 - 2026)
Geron's (GERN) quarterly Inventory Average came in at $128.4 million in Q2 2026, up 104.94% year-over-year from $62.7 million in Q2 2025, and up 2.79% quarter-over-quarter from $125.0 million in Q1 2026.
Analysis
Geron (GERN) Inventory Average (2024 - 2026) Analysis & Trends
Geron has disclosed Inventory Average across 3 years of filings, most recently posting $128.4 million for Q2 2026.
- In Q2 2026, Inventory Average rose 104.94% year-over-year to $128.4 million; the TTM figure through Jun 2026 stood at $128.4 million (up 104.94% YoY), while the FY2025 annual figure was $77.7 million, changed N/A from the prior year.
- Inventory Average came in at $128.4 million for Q2 2026 at Geron, up from $125.0 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $128.4 million in Q2 2026 to a low of $10.5 million in Q3 2024.
- Average Inventory Average over 3 years is $74.0 million, with a median of $72.5 million recorded in 2025.
- Year-over-year, Inventory Average jumped 681.44% in 2025 and jumped 104.94% in 2026.
- Over 3 years, Inventory Average stood at $29.5 million in 2024, then jumped by 259.44% to $106.0 million in 2025, then climbed by 21.14% to $128.4 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $128.4 million in Q2 2026, $125.0 million in Q1 2026, and $106.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | 128.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 128.45 Mn |
| Mar 31, 2026 | 124.96 Mn |
| Dec 31, 2025 | 106.03 Mn |
| Sep 30, 2025 | 82.27 Mn |
| Jun 30, 2025 | 62.67 Mn |
| Mar 31, 2025 | 47.47 Mn |
| Dec 31, 2024 | 29.50 Mn |
| Sep 30, 2024 | 10.53 Mn |